SOURCE: Venue Marketing Group

Venue Marketing Group

January 28, 2010 15:22 ET

Children's AccuDial Over-the-Counter Pediatric Medications Launch in Canada

Weight-Based Dosing Now Available for Canadian Children

PALM BEACH GARDENS, FL--(Marketwire - January 28, 2010) - AccuDial® Pharmaceutical, Inc. delivered a power-packed launch with their new family of eight over-the-counter (OTC) medications in Canada. Colorful floor displays enjoyed prominent placement in every Quebec Walmart pharmacy, and were filled with AccuDial's pain and fever, allergy, and cough and cold pediatric medications.

By the end of March, Children's AccuDial should be available in over 50% of Canadian pharmacies including other major grocery and drugstore outlets. A robust advertising campaign with full-page color magazine ads, embedded online banners featuring the smiling AccuKid™, and strategic Web marketing initiatives and search engine optimization, are aligned to reach consumers and medical professionals.

Recently, the popular daytime TV show "The Doctors" featured a segment on weight-based dosing with pediatrician Dr. Jim Sears. "Studies show that children are given inaccurate doses of over-the-counter medication over 50% of the time," Dr. Sears stated. He went on to say that, "as pediatricians, we always dose by weight. The AccuDial weight-based label gives specific doses by weight... and it comes with its own dosing spoon, so it's accurate."

AccuDial Pharmaceutical's patented, weight-based dosing products were designed to effectively administer its children's pain and fever, allergy, and cough and cold medications. A parent simply turns the label until their child's weight appears in the viewing window and the correct dose is shown below the weight. A dosing spoon is included in each package so parents can easily measure and administer the medication.

"AccuDial allows parents and caregivers to give their children medication based on their weight, not their age," said Bob Terwilliger, president and CEO of AccuDial Pharmaceutical. "In every discussion I've had with over 2,000 pediatricians, family physicians, and pharmacists," Terwilliger continued, "they all agreed with Dr. Sears that health care professionals dose by weight, not by age. Children the same age DO NOT weigh the same, and that's why all Children's AccuDial medications provide dosing directions based on your child's weight."

AccuDial's family of eight pediatric, OTC medications was approved by Health Canada last year. Children's AccuDial is the only medication that provides weight-specific dosing using a rotating label.

For more information, visit or contact Enid Atwater at 561.844.1778 ext. 21 or To download photos for use with this press release, visit our Flickr account at

About AccuDial Pharmaceutical, Inc.:

AccuDial® is a patented, weight-based dosing product that administers over-the-counter medications safely and effectively by doses according to a child's weight. The outer label of AccuDial's patented, two-part labeling product rotates around the bottle. A parent or caregiver simply turns the outer label until the child's weight in pounds (lbs) or kilograms (kg) is displayed in a window, and the appropriate, weight-based dose in milliliters (mL) is displayed below the child's weight. The medicine is then administered with the included AccuDial dosing spoon calibrated in mL and 1/2 mL for complete efficiency. Using AccuDial pediatric products will greatly reduce underdosing, which limits the effectiveness of pediatric medicine on children, and also greatly reduces overdosing, which may be harmful to children. Children's AccuDial is the only medication that provides weight-specific dosing using a rotating label.

The information contained in this press release includes "forward-looking statements." All statements other than statements of historical facts included in this press release, including the Company's prospects, plans, financial position, and business strategy, may constitute forward-looking statements. These statements are based on the beliefs and assumptions of our management and on the information currently available to our management at the time of such statements. Forward-looking statements generally can be identified by the words "believes," "projects," "expects," "anticipates," "intends," "plans," "estimates," or similar expressions that indicate future events and trends. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, the Company can give no assurance that these expectations will prove to be correct, and the Company's actual results may differ significantly from the results discussed in these forward-looking statements.

The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as the result of new information, future events, or otherwise.

Contact Information